Financial Information of Aakaar Medical Technologies Limited IPO
The Revenues from operations for the Fiscals ended on Mar 31, 2025, 2024 and 2023 were ₹
6,176.07 Lakh, ₹ 4,627.04 Lakh and ₹ 3,287.85 Lakh. The EBITDA for the Fiscals ended on Mar 31, 2025, 2024 and 2023 were ₹ 991.48 Lakh, ₹ 515.83 Lakh and ₹ 362.25 Lakh. The Profit after Tax for the Fiscals ended on Mar 31, 2025, 2024 and 2023 were were ₹ 603.95 Lakh, ₹ 287.02 Lakh and ₹ 215.32 Lakh respectively. This indicates a steady growth in financial performance.
| Period Ended | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 |
|---|---|---|---|
| Reserve of Surplus | 1,278.04 | 1,184.16 | 896.07 |
| Total Assets | 5,410.44 | 3,400.89 | 2,322.87 |
| Total Borrowings | 2,368.34 | 1,588.69 | 653.66 |
| Fixed Assets | 22.81 | 27.13 | 35.52 |
| Cash | 555.08 | 29.97 | 18.92 |
| Net Borrowing | 1,813.26 | 1,558.72 | 634.74 |
| Revenue | 6,176.07 | 4,627.04 | 3,287.85 |
| EBITDA | 991.48 | 515.83 | 362.25 |
| PAT | 603.95 | 287.02 | 215.32 |
| EPS | 6.13 | 3.14 | 236 |
Note 1:- RoE, ROCE & RoNW calculation in KPI is based on 31st Mar, 2025 Data, given in RHP.
Note 2:- Pre EPS and Post EPS calculation in KPI is based (Profit/Loss for the Year) on 31st Mar, 2025 Data, given in RHP.
Note 3:- RoNW calculation in KPI is based on 31st Mar, 2025 Data, given in RHP.
Note 4:- Price to Book Value calculation in KPI is based on Cap Price Post Issue, given in RHP.
Copyright @2020 Design & Developed by Info Web Software